Suppression of Th17 differentiation by IEX-1
In fighting various invaders, naïve T cells differentiate into distinct T-cell subsets, including Th1, Th2, Th17, and T regulatory (Treg) cells, which must be delicately balanced so that the invader can be sufficiently eliminated, while causing no harm to our body. IEX-1 can be rapidly induced in T cells following activation and protects them from apoptosis by modulating the production of reactive oxygen species (ROS) in mitochondria.
Mice with targeted IEX-1 expression to lymphocytes develop a lupus-like autoimmune disease and T cell lymphoma due to insufficient apoptosis of Th1-like cells. Consistent with a role for IEX-1 in a T cell subset-specific manner, null mutation of IEX-1 renders CD4+ T cells an intrinsic tendency to differentiate into Th17 cells relative to wild type (WT) CD4+ T cells. These observations argue a vital role for IEX-1 in regulation of the survival and/or differentiation of one T cell subset over the other.
Thus, its dysregulation, irrespective of overexpression or deletion both causes an imbalance in immune responses, and thus immune disorders.
Projects
- Suppression of Th17 differentiation by IEX-1
- IEX-1 can be a potential target for prevention of colitis and colon cancer
- Hypertension onset independent of inflammation
- Laser vaccine adjuvant effects
- A complex interaction between Gαi2 and Gαi3
- A linkage of Gαi2 and TGF-β signaling via a newly discovered Smad phosphatase